These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32467311)

  • 21. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
    Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
    Tanaka I; Chakraborty A; Saulnier O; Benoit-Pilven C; Vacher S; Labiod D; Lam EWF; Bièche I; Delattre O; Pouzoulet F; Auboeuf D; Vagner S; Dutertre M
    Nucleic Acids Res; 2020 Mar; 48(5):2676-2693. PubMed ID: 31943118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity.
    Neumann DP; Goodall GJ; Gregory PA
    Semin Cell Dev Biol; 2018 Mar; 75():50-60. PubMed ID: 28789987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition.
    Reinke LM; Xu Y; Cheng C
    J Biol Chem; 2012 Oct; 287(43):36435-42. PubMed ID: 22961986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition.
    Kim YE; Won M; Lee SG; Park C; Song CH; Kim KK
    Oncogene; 2019 Sep; 38(38):6521-6536. PubMed ID: 31358901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pro-metastasis effect of circANKS1B in breast cancer.
    Zeng K; He B; Yang BB; Xu T; Chen X; Xu M; Liu X; Sun H; Pan Y; Wang S
    Mol Cancer; 2018 Nov; 17(1):160. PubMed ID: 30454010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A complex epigenome-splicing crosstalk governs epithelial-to-mesenchymal transition in metastasis and brain development.
    Sahu SK; Agirre E; Inayatullah M; Mahesh A; Tiwari N; Lavin DP; Singh A; Strand S; Diken M; Luco RF; Belmonte JCI; Tiwari VK
    Nat Cell Biol; 2022 Aug; 24(8):1265-1277. PubMed ID: 35941369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition.
    Aparicio LA; Abella V; Valladares M; Figueroa A
    Cell Mol Life Sci; 2013 Dec; 70(23):4463-77. PubMed ID: 23715860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide activities of RNA binding proteins that regulate cellular changes in the epithelial to mesenchymal transition (EMT).
    Bebee TW; Cieply BW; Carstens RP
    Adv Exp Med Biol; 2014; 825():267-302. PubMed ID: 25201109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miRNA-Mediated KHSRP Silencing Rewires Distinct Post-transcriptional Programs during TGF-β-Induced Epithelial-to-Mesenchymal Transition.
    Puppo M; Bucci G; Rossi M; Giovarelli M; Bordo D; Moshiri A; Gorlero F; Gherzi R; Briata P
    Cell Rep; 2016 Jul; 16(4):967-978. PubMed ID: 27396342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF.
    Huang H; Zhang J; Harvey SE; Hu X; Cheng C
    Genes Dev; 2017 Nov; 31(22):2296-2309. PubMed ID: 29269483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.
    He M; Hu F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.
    Yang J; Bennett BD; Luo S; Inoue K; Grimm SA; Schroth GP; Bushel PR; Kinyamu HK; Archer TK
    Mol Cell Biol; 2015 Sep; 35(18):3225-43. PubMed ID: 26149387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.
    Rokavec M; Kaller M; Horst D; Hermeking H
    Sci Rep; 2017 Jul; 7(1):4687. PubMed ID: 28680090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.
    Yao J; Caballero OL; Huang Y; Lin C; Rimoldi D; Behren A; Cebon JS; Hung MC; Weinstein JN; Strausberg RL; Zhao Q
    Cancer Immunol Res; 2016 Jun; 4(6):552-61. PubMed ID: 27045022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state.
    Katz Y; Li F; Lambert NJ; Sokol ES; Tam WL; Cheng AW; Airoldi EM; Lengner CJ; Gupta PB; Yu Z; Jaenisch R; Burge CB
    Elife; 2014 Nov; 3():e03915. PubMed ID: 25380226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing.
    Iwata T; Kishikawa T; Seimiya T; Notoya G; Suzuki T; Shibata C; Miyakawa Y; Odawara N; Funato K; Tanaka E; Yamagami M; Sekiba K; Otsuka M; Koike K; Fujishiro M
    J Biol Chem; 2024 Mar; 300(3):105742. PubMed ID: 38346537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.